Jim Datin

Jim Datin is an accomplished operating partner at GHO Capital Partners LLP since January 2023 and has a diverse portfolio of leadership roles, including serving as a member of the Board of Trustees for the North Carolina Symphony and a board member and investor for North Carolina Courage. Datin has held significant positions such as Vice Chairman of the Board at the North Carolina Biotechnology Center and a board member at OraSure Technologies. With an extensive background in the life sciences sector, Datin's previous roles include President and CEO of FSD Pharma Inc. and board memberships at BioAgilytix and Life Sciences Pennsylvania. Datin's educational credentials include an Advance Management Degree from The Wharton School, an Executive MBA from the University of New Haven, and a Bachelor of Business Administration in Marketing from Marshall University.